Welcome to LookChem.com Sign In|Join Free
  • or
5-cyclopropyl-2-(4-fluorophenyl)-N-methyl-6-(methylsulfonamido)benzofuran-3-carboxamide is a chemical compound that belongs to the benzofuran class. It is a derivative of N-methyl-6-(methylsulfonamido)benzofuran-3-carboxamide, and it contains a cyclopropyl, fluorophenyl, and N-methyl groups. 5-cyclopropyl-2-(4-fluorophenyl)-N-methyl-6-(methylsulfonamido)benzofuran-3-carboxamide may have potential pharmacological or biological activities due to its structural characteristics.

691856-35-6

Post Buying Request

691856-35-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

691856-35-6 Usage

Uses

Used in Pharmaceutical Development:
5-cyclopropyl-2-(4-fluorophenyl)-N-methyl-6-(methylsulfonamido)benzofuran-3-carboxamide is used as a potential candidate for the development of pharmaceutical drugs for various medical purposes. Its unique structural features may contribute to its pharmacological or biological activities, making it a promising compound for further research and testing.
However, it is important to note that the specific applications and industries for 5-cyclopropyl-2-(4-fluorophenyl)-N-methyl-6-(methylsulfonamido)benzofuran-3-carboxamide have not been provided in the materials. Further research and testing are needed to fully understand its properties and potential applications in various fields.

Check Digit Verification of cas no

The CAS Registry Mumber 691856-35-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,9,1,8,5 and 6 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 691856-35:
(8*6)+(7*9)+(6*1)+(5*8)+(4*5)+(3*6)+(2*3)+(1*5)=206
206 % 10 = 6
So 691856-35-6 is a valid CAS Registry Number.

691856-35-6Downstream Products

691856-35-6Relevant academic research and scientific papers

INHIBITORS OF HEPATITIS C VIRUS POLYMERASE

-

Paragraph 219; 230, (2016/10/11)

The present invention provides, among other things, compounds represented by the general Formula I: (I) and pharmaceutically acceptable salts thereof, wherein L and A (and further substituents) are as defined in classes and subclasses herein and compositions (e.g., pharmaceutical compositions) comprising such compounds, which compounds are useful as inhibitors of hepatitis C virus polymerase, and thus are useful, for example, as medicaments for the treatment of HCV infection.

THERAPEUTIC METHODS

-

Page/Page column 56, (2013/03/26)

The present invention features a method for the treatment of Hepatitis C in a human in need thereof comprising administering a compound of Formulas (II) or (IIB) described herein or a pharmaceutically acceptable salt thereof in combination with one or more alternative Hepatitis C therapeutic agents

BENZOFURAN COMPOUNDS FOR THE TREATMENT OF HEPATITIS C VIRUS INFECTIONS

-

Page/Page column 36, (2013/03/26)

The present invention features compounds of formula (I) and salts thereof, pharmaceutical compositions comprising said compounds, and uses of such compounds in treating or preventing viral infections, such as HCV infections, and diseases associated with such infections.

6-SUBSTITUTED BENZOFURAN COMPOUNDS TO TREAT INFECTION WITH HEPATITIS C VIRUS

-

Page/Page column 23, (2010/01/29)

Compounds of following formula (I); wherein R1, R2, R3, R4, R5, and R6 are as defined herein, including all crystalline forms and pharmaceutically acceptable salts thereof, which are useful in pharmaceutical formulations for the treatment or prevention of

COMBINATION THERAPY METHOD FOR TREATING HEPATITIS C VIRUS INFECTION AND PHARMACEUTICAL COMPOSITIONS FOR USE THEREIN

-

Page/Page column 18, (2008/06/13)

Combination therapy methods for the treatment of hepatitis C virus infection and associated diseases, by the co-administration of 5-cyclopropyl-2- (4-fluoro-phenyl-6-[(2-hydroxy-ethyl)-methanesulfonyl-amino]-benzofuran- 3-carboxylic acid methylamide or a pharmaceutically acceptable salt thereof with natural, recombinant or modified interferon, that effectively inhibit viral replication.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 691856-35-6